Methods for evaluating the effects of new hormone replacement therapy compounds on coronary artery disease

Research output: Contribution to journalArticle

Abstract

The clinical effect of hormone replacement therapy (HRT) on cardiovascular disease, and whether this effect is altered by the formulation of estrogen or progestin studied, is an area of controversy. Use of clinical end points for these studies requires large numbers of subjects observed for several years and is time consuming and costly. The selection of clinically relevant surrogate endpoints, however, is complex, because many of the currently available modalities are not sensitive enough to identify subclinical coronary disease or disease progression. Moreover, many of the existing choices are invasive and may not be appropriate for repeated assessment of disease. This article reviews some of the available diagnostic tools, including measures of arterial structure and function, intravascular ultrasound, and electron-beam computed tomography, and assesses their ability to evaluate the presence and severity of atherosclerosis and the impact of HRT on coronary artery disease progression.

Original languageEnglish (US)
JournalThe American Journal of Cardiology
Volume90
Issue number1 SUPPL. 1
StatePublished - Jul 3 2002

Fingerprint

Hormone Replacement Therapy
Disease Progression
Coronary Artery Disease
X Ray Computed Tomography
Progestins
Coronary Disease
Atherosclerosis
Estrogens
Cardiovascular Diseases
Biomarkers

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

@article{9d25824d37d44c749fdb20a5f95490f8,
title = "Methods for evaluating the effects of new hormone replacement therapy compounds on coronary artery disease",
abstract = "The clinical effect of hormone replacement therapy (HRT) on cardiovascular disease, and whether this effect is altered by the formulation of estrogen or progestin studied, is an area of controversy. Use of clinical end points for these studies requires large numbers of subjects observed for several years and is time consuming and costly. The selection of clinically relevant surrogate endpoints, however, is complex, because many of the currently available modalities are not sensitive enough to identify subclinical coronary disease or disease progression. Moreover, many of the existing choices are invasive and may not be appropriate for repeated assessment of disease. This article reviews some of the available diagnostic tools, including measures of arterial structure and function, intravascular ultrasound, and electron-beam computed tomography, and assesses their ability to evaluate the presence and severity of atherosclerosis and the impact of HRT on coronary artery disease progression.",
author = "Pamela Ouyang",
year = "2002",
month = "7",
day = "3",
language = "English (US)",
volume = "90",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "1 SUPPL. 1",

}

TY - JOUR

T1 - Methods for evaluating the effects of new hormone replacement therapy compounds on coronary artery disease

AU - Ouyang, Pamela

PY - 2002/7/3

Y1 - 2002/7/3

N2 - The clinical effect of hormone replacement therapy (HRT) on cardiovascular disease, and whether this effect is altered by the formulation of estrogen or progestin studied, is an area of controversy. Use of clinical end points for these studies requires large numbers of subjects observed for several years and is time consuming and costly. The selection of clinically relevant surrogate endpoints, however, is complex, because many of the currently available modalities are not sensitive enough to identify subclinical coronary disease or disease progression. Moreover, many of the existing choices are invasive and may not be appropriate for repeated assessment of disease. This article reviews some of the available diagnostic tools, including measures of arterial structure and function, intravascular ultrasound, and electron-beam computed tomography, and assesses their ability to evaluate the presence and severity of atherosclerosis and the impact of HRT on coronary artery disease progression.

AB - The clinical effect of hormone replacement therapy (HRT) on cardiovascular disease, and whether this effect is altered by the formulation of estrogen or progestin studied, is an area of controversy. Use of clinical end points for these studies requires large numbers of subjects observed for several years and is time consuming and costly. The selection of clinically relevant surrogate endpoints, however, is complex, because many of the currently available modalities are not sensitive enough to identify subclinical coronary disease or disease progression. Moreover, many of the existing choices are invasive and may not be appropriate for repeated assessment of disease. This article reviews some of the available diagnostic tools, including measures of arterial structure and function, intravascular ultrasound, and electron-beam computed tomography, and assesses their ability to evaluate the presence and severity of atherosclerosis and the impact of HRT on coronary artery disease progression.

UR - http://www.scopus.com/inward/record.url?scp=0037014386&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037014386&partnerID=8YFLogxK

M3 - Article

VL - 90

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 1 SUPPL. 1

ER -